Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
The incretins address most of the proposed pathophysiologic mechanisms involved in the development of T2D (Figure 2)
The three-way comparison of semaglutide, tirzepatide, and retatrutide provides context on how these medications differ in mechanism, efficacy, and expected pricing
Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease
Orforglipron treatment was also associated with slower gastric emptying time and short-term weight loss, all of which are consistent with drug class effects , with up to 5.4 kg loss over 4 weeks in higher-dose cohorts
US$ 26.09
US$ 20.35
US$ 25.45
US$ 25.84
